TARS
Tarsus Pharmaceuticals, Inc.
Key figures
| Metric | Last 12 months |
|---|---|
| Revenue | $682M |
| Gross profit | $636M |
| Operating income | −$696M |
| Net income | −$702M |
| EPS | −$15.19 |
| Free cash flow | $32M |
Tarsus Pharmaceuticals, Inc.
| Metric | Last 12 months |
|---|---|
| Revenue | $682M |
| Gross profit | $636M |
| Operating income | −$696M |
| Net income | −$702M |
| EPS | −$15.19 |
| Free cash flow | $32M |